Smart messages and alerts for an infusion delivery and management system
First Claim
Patent Images
1. A method of preventing nocturnal hypoglycemia with an analyte monitoring system, the method comprising:
- detecting, by a first electronic device of the analyte monitoring system, a pre-sleep time period comprising a time period prior to when a user enters a sleep cycle, wherein the first electronic device enters a pre-sleep mode in response thereto;
performing, by the first electronic device, the following steps without user input, during the pre-sleep time period;
receiving, from a second electronic device of the analyte monitoring system, a predetermined number of consecutive analyte level readings for the pre-sleep time period, wherein the predetermined number of consecutive analyte level readings includes two or more consecutive analyte level readings;
comparing each of the predetermined number of consecutive analyte level readings for the pre-sleep time period to a target analyte level for the pre-sleep time period; and
exiting, by the first electronic device, the pre-sleep mode and waiting for a subsequent pre-sleep time period in response to a first threshold number of the predetermined number of consecutive analyte level readings being greater than the target analyte level.
1 Assignment
0 Petitions
Accused Products
Abstract
Method and system for providing diabetes management is provided.
-
Citations
20 Claims
-
1. A method of preventing nocturnal hypoglycemia with an analyte monitoring system, the method comprising:
-
detecting, by a first electronic device of the analyte monitoring system, a pre-sleep time period comprising a time period prior to when a user enters a sleep cycle, wherein the first electronic device enters a pre-sleep mode in response thereto; performing, by the first electronic device, the following steps without user input, during the pre-sleep time period; receiving, from a second electronic device of the analyte monitoring system, a predetermined number of consecutive analyte level readings for the pre-sleep time period, wherein the predetermined number of consecutive analyte level readings includes two or more consecutive analyte level readings; comparing each of the predetermined number of consecutive analyte level readings for the pre-sleep time period to a target analyte level for the pre-sleep time period; and exiting, by the first electronic device, the pre-sleep mode and waiting for a subsequent pre-sleep time period in response to a first threshold number of the predetermined number of consecutive analyte level readings being greater than the target analyte level. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11)
-
-
12. A method of preventing nocturnal hypoglycemia with an analyte monitoring system, the method comprising:
-
programming a first electronic device of the analyte monitoring system with a pre-sleep mode to define a pre-sleep time period by specifying a user-specific meal or sleep schedule; detecting, by the first electronic device, the pre-sleep time period, wherein the first electronic device enters the pre-sleep mode in response thereto; performing, by the first electronic device, the following steps, without user input, during the pre-sleep time period; receiving, from a second electronics device of the analyte monitoring system, a predetermined number of consecutive analyte level readings for the pre-sleep time period, wherein the predetermined number of consecutive analyte level readings includes two or more consecutive analyte level readings; comparing each of the predetermined number of consecutive analyte level readings for the pre-sleep time period to a target analyte level for the pre-sleep time period; exiting by the first electronic device, the pre-sleep mode and waiting for a subsequent pre-sleep time period in response to a first threshold number of the predetermined number of consecutive analyte level readings being greater than the target analyte level; and generating and outputting an alert in response to a second threshold number of the predetermined number of consecutive analyte level readings being equal to or lower than the target analyte level. - View Dependent Claims (13, 14, 15, 16, 17, 18, 19, 20)
-
Specification